Clinical Trial of TQB2858 Injection in the Treatment of Advanced High-grade Sarcoma
Clinical trial NCT05262101 · TERMINATED
Trial details
- NCT number
- NCT05262101
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-09
- Primary completion
- 2023-06-28
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.